Responses
Clinical/translational cancer immunotherapy
Original research
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.